AlenCiken

Full Commercial Launch of Tigereye(TM) Image-Guided CTO Crossing

NASDAQ:AVGR   Avinger, Inc.
Avinger Initiates Full Commercial Launch of Tigereye(TM) Image-Guided CTO Crossing Catheter

With the initiation of full commercial launch, current and prospective accounts throughout the US and Germany are now able to order the Tigereye device.

During the fourth quarter of 2020, Avinger conducted a limited launch at 12 clinical centers in the U.S. and Germany. Approximately 50 CTO cases were successfully performed, showcasing Tigereye's advanced clinical capabilities and excellent product reliability in a variety of lesion types and settings.

The limited launch program demonstrated Tigereye's strong clinical results and efficiency across a wide range of PAD cases

"We believe full commercial availability of the Tigereye device will be an important contributor to expanding our revenue growth opportunities in 2021, both in terms of attracting new Avinger user sites and supporting higher utilization per site,"

finance.yahoo.com/ne...aunch-133000095.html


Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.